Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Teva
Johnson and Johnson
McKesson
Citi
Fuji
QuintilesIMS
Harvard Business School
McKinsey

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078976

« Back to Dashboard

Summary for 078976
Tradename:LEVETIRACETAM
Applicant:Actavis Mid Atlantic
Ingredient:levetiracetam
Patents:0
Therapeutic Class:Anticonvulsants
Formulation / Manufacturing:see details
Pharmacology for NDA: 078976
Suppliers and Packaging for NDA: 078976
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LEVETIRACETAM levetiracetam SOLUTION;ORAL 078976 ANDA Actavis Pharma, Inc. 0472-0235 N 0472-0235-16
LEVETIRACETAM levetiracetam SOLUTION;ORAL 078976 ANDA VistaPharm, Inc 66689-028 N 66689-028-50

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrength100MG/ML
Approval Date:Jan 15, 2009TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Army
Johnson and Johnson
Fuji
Chubb
Queensland Health
Accenture
Mallinckrodt
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.